Arbutus Biopharma
ABUS
#6232
Rank
A$1.29 B
Marketcap
A$6.72
Share price
-1.33%
Change (1 day)
16.80%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): A-$0.50

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is A-$0.50. In 2024 the company made an earnings per share (EPS) of A-$0.57 an increase over its 2023 EPS that were of A-$0.66.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.50-12.19%
2024A-$0.57-13.64%
2023A-$0.66-4.35%
2022A-$0.69-44.58%
2021A-$1.25-17%
2020A-$1.51-65.4%
2019A-$4.35138.84%
2018A-$1.82-22.44%
2017A-$2.35-78.45%
2016A-$10.90424.64%
2015A-$2.08-20.19%
2014A-$2.6087.96%
2013A-$1.39-142.59%
2012A$3.25-342.7%
2011A-$1.34-25.82%
2010A-$1.8147.8%
2009A-$1.22-43.55%
2008A-$2.17158.91%
2007A-$0.84-111.88%
2006A$7.04-552.53%
2005A-$1.56-71.77%
2004A-$5.51-14.48%
2003A-$6.45-8.95%
2002A-$7.0870.07%
2001A-$4.1648.01%
2000A-$2.81-38.54%
1999A-$4.57-24.6%
1998A-$6.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
NRC Health
NRC
A$1.05-312.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
A-$0.09035-81.82% Bahamas